In this multicenter , randomized , double-blind , placebo-controlled study involving @ patients , we evaluated the safety and effectiveness of enzyme-replacement therapy with sebelipase alfa ( administered intravenously at a dose of @ mg per kilogram of body weight every other week ) ; the placebo-controlled phase of the study was @ weeks long and was followed by open-label treatment for all patients .